Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

EPRXEPRX
4 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in EUPRAXIA PHARMACEUTICALS INC

BALYASNY ASSET MANAGEMENT L.P. holds 1.4M shares of EPRX (EUPRAXIA PHARMACEUTICALS INC), worth $8.9M as of 2026-Q2. The position was increased. EPRX represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$8.9M

Current Shares

1.4M

Total Value Change

+$958,599

Total Shares Change

+15

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
0.0%
$8.9M0.0%$6.61
27
2026-Q1
Unchanged
1.4M
0.0%
$9.8M0.0%$8.02
0
2025-Q4
Unchanged
1.4M
0.0%
$10.2M0.0%$7.59
0
2025-Q3
New
1.4M
-
$8M0.0%$5.75
38

Other major holders of EPRX: SCOTIA CAPITAL INC., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used